Sector portfolio · Investment firm · United States

NC

National Cancer Institute (NCI)'s Biotech portfolio

National Cancer Institute (NCI) has backed 34 Biotech startups in rounds we track, $361M between them, shown by the stage each has reached. The best-funded is Igenica.

34startups backed
4stages
$361Mraised between them
Stage not reportedbiggest stage

National Cancer Institute (NCI)'s whole portfolioNational Cancer Institute (NCI)'s profile

Stage not reported

27

+3 more

Series B

3

Series A

2

Pre-seed and seed

2

Segment by segment

Stage not reported

27 startups · $217M raised

  1. IIgenicaIgenica engages in discovery and development of antibody-based therapeutics for the treatment of cancer.United States$88M
  2. Tiga TXTiga TX develops an IgA therapeutic monoclonal antibody platform for the treatment of solid tumors.United States$36M
  3. Linnaeus TherapeuticsLinnaeus Therapeutics is a development stage biotech company that develops and commercializes drugs for cancer.United States$32M
  4. Transcode TherapeuticsTransCode Therapeutics is an RNA oncology company that develops and commercializes drugs for the treatment of metastatic cancer.United States$26M
  5. Microvascular TherapeuticsMicrovascular Therapeutics is a biotechnology company specializing in ultrasound contrast and theranostics for diagnosis.United States$4.0M
  6. HelocyteHelocyte is a clinical-stage biopharmaceutical company developing novel immunotherapies for the prevention and treatment of cancer.United States$3.2M
  7. Resolute ScienceResolute is creating a new class of medicines for aggressive solid tumors that are uncommon and challenging to treat.United States$2.9M
  8. Lamassu PharmaLamassu Pharma is a biotech startup that solves the critical unmet medical need for severe acute pancreatitis.United States$2.7M

Series B

3 startups · $109M raised

  1. CTChrono TherapeuticsChrono Therapeutics was founded by Guy DiPierro to cause a paradigm shift in the way addictions and diseases are treated.United States$83M
  2. PrevisePrevise is a London-based financial services and technology company that focuses on improving payment processes for businesses.United Kingdom$23M
  3. ImmunicomImmunicom is a biotechnology company.United States$3.9M

Series A

2 startups · $21M raised

  1. AiM Medical RoboticsAiM Medical Robotics is a privately held company based in Worcester, Massachusetts, focused on developing a portable, MRI-compatibUnited States$16M
  2. AgilvaxAgilvax is a biotechnological company that focuses on the discovery and development of immunotherapies and targeted vaccines.United States$4.7M

Pre-seed and seed

2 startups · $14M raised

  1. Vivere OncotherapiesVivere Oncotherapies is a biotechnology company based in Berkeley, California, founded in 2022.United States$10M
  2. MBModifi BioModifi Biosciences is a leader in direct DNA modification and the development of novel cancer therapeutics.United States$4.3M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names National Cancer Institute (NCI) as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Portfolio mapNational Cancer Institute (NCI) portfolio map47 startups · $494MSector portfolioNational Institute of Allergy and Infectious Diseases' Biotech portfolio28 startups · $407MSector portfolioMayo Clinic's Healthtech portfolio22 startups · $2.1BSector portfolioMayo Clinic's Biotech portfolio19 startups · $479MSector portfolioAVP's AI portfolio17 startups · $1.1BSector portfolioSquare 1 Bank's Biotech portfolio14 startups · $1.6B

Raising from investors like National Cancer Institute (NCI)?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps